Moonlight Therapeutics
Home
About
Focus
News
Contact
More
Moonlight is pioneering a novel intradermal therapy to transform the lives of people living with food allergies
MOON101 is designed with the potential to be a best-in-class differentiated treatment for peanut allergy
Funding
Moonlight has raised private funds and received a new grant from the U.S. Defense Health Agency's CDMR program
Publication
MOON101, an intradermal stamp, worn for just a few minutes at a time successfully desensitized peanut-allergic mice.
Regulatory
Moonlight Therapeutics Receives FDA Clearance of IND Application for MOON101
